Anaerobic Infections in Children

  • Itzhak BrookEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 697)


Anaerobic bacteria commonly cause infection in children. Anaerobes are the most predominant components of the normal human skin and mucous membranes bacterial flora and are therefore a common cause of bacterial infections of endogenous origin. Because of their fastidious nature, they are difficult to isolate from infectious sites and are often overlooked. Anaerobic infections can occur in all body sites, including the central nervous system, oral cavity, head and neck, chest, abdomen, pelvis, skin, and soft tissues. They colonize the newborn after delivery and have been recovered from several types of neonatal infections. These include cellulitis of the site of fetal monitoring, neonatal aspiration pneumonia, bacteremia, conjunctivitis, omphalitis, and infant botulism. The failure to direct adequate therapy against these organisms may lead to clinical failures. Their isolation requires appropriate methods of collection, transportation, and cultivation of specimens. Treatment of anaerobic infection is complicated by the slow growth of these organisms, by their polymicrobial nature, and by the growing resistance of anaerobic bacteria to antimicrobials. Antimicrobial therapy is often the only form of therapy required, whereas in others it is an important adjunct to a surgical approach. Because anaerobic bacteria generally are recovered mixed with aerobic organisms, the choice of appropriate antimicrobial agents should provide for adequate coverage of both types of pathogen.


Anaerobic Bacterium Bacterial Vaginosis Brain Abscess Chronic Otitis Medium Chronic Suppurative Otitis Medium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Gibbons RJ. Aspects of the pathogenicity and ecology of the indigenous oral flora of man. In: Ballow A, Dehaan RM, Dowell VR, Guze LB, editors. Anaerobic bacteria: role in disease. Springfield, IL: Charles C. Thomas Publisher; 1974. p. 267–285.Google Scholar
  2. 2.
    Gorbach SL. Intestinal microflora. Gastroenterology. 1971;60(6):1100–29.Google Scholar
  3. 3.
    Finegold SM. Anaerobic infections in humans: an overview. Anaerobe. 1995;1(1):3–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Brook I. “Anaerobic Infections Diagnosis and Management”. A Textbook. New York, NY: Informa Healthcare USA, Inc; 2007.Google Scholar
  5. 5.
    Summanen P, Baron EJ, Ciron DM et al. Wadsworth anaerobic bacteriology manual. 5th ed. Belmont, CA: Star Publishing; 1993.Google Scholar
  6. 6.
    Finegold SM. Anaerobic Bacteria in Human Disease. Orlando, FL: Academic Press; 1977.Google Scholar
  7. 7.
    Jousimies H, Summanen P. Recent taxonomic changes and terminology update of clinically significant anaerobic gram-negative bacteria (excluding spirochetes). Clin Infect Dis. 2002;35(Suppl 1):S17–S21.CrossRefGoogle Scholar
  8. 8.
    Hurst DL, Marsh WW. Early severe infantile botulism. J Pediatr. 1993;122(6):909–11.CrossRefPubMedGoogle Scholar
  9. 9.
    Hatheway CL. Toxogenic clostridia. Clin Microbiol Rev. 1990;3(1):66–98.PubMedGoogle Scholar
  10. 10.
    Bartlett JG. The New Epidemic of Clostridium difficile-Associated Enteric Disease. Ann Intern Med. 2006;145(1):758–64.PubMedGoogle Scholar
  11. 11.
    Brook I. Infections caused by Propionibacterium in children. Clin Pediatr. 1994;33(8):485–90.CrossRefGoogle Scholar
  12. 12.
    Brook I. Prevotella and Porphyromonas infections in children. J Med Microbiol. 1995;42:340–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Brook I. Fusobacterial infection in children. J Infect. 1994;28(2):155–65.CrossRefPubMedGoogle Scholar
  14. 14.
    Rosenblatt JE, Brook I. Clinical relevance of susceptibility testing of anaerobic bacteria. Clin Infect Dis. 1993;16(Suppl 4):S446–S48.PubMedGoogle Scholar
  15. 15.
    Brook I. Peptostreptococcal infection in children. Scand J Infect Dis. 1994;26(5):503–10.CrossRefPubMedGoogle Scholar
  16. 16.
    Brook I. Microaerophilic streptococci infection in children. Infection. 1994;28(30):241–9.Google Scholar
  17. 17.
    Brook I. Veillonella infection in children. J Clin Microbiol. 1996;34(5):1281–5.Google Scholar
  18. 18.
    Larsen B. Vaginal flora in health and disease. Clin Obstet Gynecol. 1993;36(1):107–21.CrossRefPubMedGoogle Scholar
  19. 19.
    Hay P. Recurrent bacterial vaginosis. Curr Opin Infect Dis. 2009;22(1):82–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Brook I. Enhancement of growth of aerobic and facultative bacteria in mixed infections with Bacteroides sp. Infect Immun. 1985;50(3):929–31.PubMedGoogle Scholar
  21. 21.
    Brook I, Myhal LA, Dorsey HC. Encapsulated and pilus formation of Bacteroides sp. J Infect. 1991;25(3):251–7.CrossRefGoogle Scholar
  22. 22.
    Hofstad T. Virulence determinants in non-spore-forming bacteria. Scand J Infect Dis. 1989;62(Suppl 1):15–24.Google Scholar
  23. 23.
    Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6(5):601–7.PubMedGoogle Scholar
  24. 24.
    Jousimies-Somer HR, Summanen P, Baron EJ, Citron DM, Wexler HM, Finegold SM. Wadsworth-KTL anaerobic bacteriology manual. 6th ed. Belmont, CA: Star Publishing; 2002.Google Scholar
  25. 25.
    Brook I. Aerobic and anaerobic bacteriology of intracranial abscesses. Pediatr Neurol. 1992;8(3):210–14.CrossRefPubMedGoogle Scholar
  26. 26.
    Brook I, Johnson N, Overturf GD, Wilkins J. Mixed bacterial meningitis: a complication of entriculo- and lumbo-peritoneal shunts. J Neurosurg. 1977;47(6):961–4.CrossRefPubMedGoogle Scholar
  27. 27.
    Brook I. Meningitis and shunt infection caused by anaerobic bacteria in children. Pediatr Neurol. 2002;26(2):99–105.CrossRefPubMedGoogle Scholar
  28. 28.
    Latchow RE, Hirsch WL Jr, Yock DH. Imagery of intracranial infection. Neurosurg Clin North Am. 1992;3(2):303–22.Google Scholar
  29. 29.
    Obana WG, Rosenblum ML. Nonoperative treatment of neurosurgical infections. Neurosurg Clin North Am. 1992;3(2):359–73.Google Scholar
  30. 30.
    Osenbach RK, Loftus CM. Diagnosis and management of brain abscess. Neurosurg Clin North Am. 1992;3(2):403–20.Google Scholar
  31. 31.
    Brook I, Grimm S, Kielich RB. Bacteriology of acute periapical abscess in children. J Endod. 1981;7(8):378–80.CrossRefPubMedGoogle Scholar
  32. 32.
    Loeshe WJ, Syed SA, Laughon BE, Stoll J. The bacteriology of acute necrotizing ulcerative gingivitis. J Periodontal. 1982;53(4):222–30.Google Scholar
  33. 33.
    Murray PM, Finegold SM. Anaerobic mediastinitis. Rev Infect Dis. 1984;6(Suppl 1):S123–S27.PubMedGoogle Scholar
  34. 34.
    Brook I, Frazier EH. Microbiology of mediastinitis. Arch Intern Med. 1996;156(3):333–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Brook I, Anthony BV, Finegold SM. Aerobic and anaerobic bacteriology of acute otitis media in children. J Pediatr. 1978;92(1):13–15.CrossRefPubMedGoogle Scholar
  36. 36.
    Brook I, Yocum P, Shah K, Feldman B, Epstein S. The aerobic and anaerobic bacteriology of serous otitis media. Am J Otolaryngol. 1983;4(6):389–92.CrossRefPubMedGoogle Scholar
  37. 37.
    Brook I. Microbiology and management of chronic suppurative otitis media in children. J Trop Pediatr. 2003;49(4):196–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Sweeney G, Picozzi GI, Browning GG. A quantitative study of aerobic and anaerobic bacteria in chronic suppurative otitis media. J Infect. 1982;5(1):47–55.CrossRefGoogle Scholar
  39. 39.
    Brook I. Aerobic and anaerobic bacteriology of cholesteatoma. Laryngoscope. 1981;91(2):250–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Lino Y, Hoshimi E, Tomioko S, Takasaka T, Kaneko Y, Yuasa R. Organic acids and anaerobic microorganisms in the contents of the cholesteatoma sac. Ann Otol Rhinol Laryngol. 1983;92(1):91–4.Google Scholar
  41. 41.
    Brook I. Aerobic and anaerobic bacteriology of chronic mastoiditis in children. Am J Dis Child. 1981;135(5):478–9.PubMedGoogle Scholar
  42. 42.
    Carenfelt C, Lundberg C. Purulent and non-purulent maxillary sinus secretions with respect to pO2 pCO2 and pH. Acta Otolaryngol. 1977;84(1-2):138–43.CrossRefPubMedGoogle Scholar
  43. 43.
    Brook I. Bacteriological features of chronic sinusitis in children. JAMA. 1981;246(9):967–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Brook I, Friedman EM, Rodriegez WJ, Controni G. Complications of sinusitis in children. Pediatrics. 1980;66(4):568–72.PubMedGoogle Scholar
  45. 45.
    Brook I, Frazier EH, Thompson DH. Aerobic and anaerobic microbiology of acute suppurative parotitis. Laryngoscope. 1991;101(2):170–2.CrossRefPubMedGoogle Scholar
  46. 46.
    Brook I. Aerobic and anaerobic bacteriology of cervical adenitis in children. Clin Pediatr. 1980;19(10):693–6.CrossRefGoogle Scholar
  47. 47.
    Bussman YC, Wong ML, Bell MJ, Santiago JV. Suppurative thyroiditis with gas formation due to mixed anaerobic infection. J Pediatr. 1977;90(2):321–2.CrossRefPubMedGoogle Scholar
  48. 48.
    Brook I. Microbiology of infected epidermal cysts. Arch Dermatol. 1989;125(12):1658–61.CrossRefPubMedGoogle Scholar
  49. 49.
    Brook I, Hirokawa R. Post surgical wound infection after head and neck cancer surgery. Ann Otol Rhinol Laryngol. 1989;98(5 Pt 1):322–5.Google Scholar
  50. 50.
    Johnson JT, Yu VL, Myers RN, Wagner RL. An assessment of the need for gram-negative bacterial coverage on antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis. 1987;155(2):331–3.PubMedGoogle Scholar
  51. 51.
    Brook I. Aerobic and anaerobic microbiology of peritonsillar abscess in children. Acta Paediatr Scand. 1981;70(6):831–5.CrossRefPubMedGoogle Scholar
  52. 52.
    Brook I, Yocum P. Comparison of the microbiology of group A streptococcal and non-group A streptococcal tonsillitis. Ann Otol Rhinol Laryngol. 1988;97(3 Pt 1):243–6.PubMedGoogle Scholar
  53. 53.
    Helstrom SA, Mandi PA, Ripa T. Treatment of infectious mononucleosis with metronidazole. Scand J Infect Dis. 1978;10(1):7–9.Google Scholar
  54. 54.
    Puto A. Febrile exudative tonsillitis: viral or streptococcal. Pediatrics. 1987;80(1):6–12.Google Scholar
  55. 55.
    Brook I, Foote PA Jr, Slots J, Jackson W. Immune response to Prevotella intermedia in patients with recurrent non-streptococcal tonsillitis. Ann Otol Rhinol Laryngol. 1993;102(2):113–16.PubMedGoogle Scholar
  56. 56.
    Brook I, Foote PA, Slots J. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with peritonsillar cellulitis and abscess. Clin Infect Dis. 1995;20(Suppl 2):S220–1.PubMedGoogle Scholar
  57. 57.
    Brook I, de Leyva F. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with infectious mononucleosis. J Med Microbiol. 1996;44(2):131–4.CrossRefPubMedGoogle Scholar
  58. 58.
    Brook I, de Leyva F. Microbiology of tonsillar surfaces in infectious mononucleosis. Arch Pediatr Adolesc Med. 1994;148(2):171–3.PubMedGoogle Scholar
  59. 59.
    Brook I, Yocum P, Friedman EM. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol. 1981;90(3 Pt 1):261–3.PubMedGoogle Scholar
  60. 60.
    Tuner K, Nord CE. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis. 1983;39:83–8.Google Scholar
  61. 61.
    Brook I, Yocum P. Comparison of the microbiology of Group A streptococcal and non-group A streptococcal tonsillitis. Ann Otolo Rhinol Laryngol. 1988;97(3 Pt 1):243–6.Google Scholar
  62. 62.
    Brook I, Yocum P. Quantitative measurement of beta-lactamase in tonsils of children with recurrent tonsillitis. Acta Otolaryngol. 1984;98(5–6):556–60.CrossRefPubMedGoogle Scholar
  63. 63.
    Kaplan EL, Johnson OR. Eradication of group A streptococci from treatment failure of the upper respiratory tract by amoxicillin with clavulanate after oral penicillin. J Pediatr. 1988;113(2):400–3.CrossRefPubMedGoogle Scholar
  64. 64.
    Brook I, Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci: A prospective randomized study comparing penicillin, erythromycin, and clindamycin. Clin Pediatr. 1985;24(6):331–6.CrossRefGoogle Scholar
  65. 65.
    Brook I, Finegold SM. Bacteriology of aspiration pneumonia in children. Pediatrics. 1980;65(6):1115–20.PubMedGoogle Scholar
  66. 66.
    Brook I. Bacterial colonization, tracheobronchitis and pneumonia, following tracheostomy and long-term intubation in pediatric patients. Chest. 1979;70(4):420–4.CrossRefGoogle Scholar
  67. 67.
    Brook I. Bacteriological studies of peritoneal cavity and postoperative surgical wound drainage following perforated appendix in children. Ann Surg. 1980;192(2):208–12.CrossRefPubMedGoogle Scholar
  68. 68.
    Bohen JMA, Solomkin JS, Dellinger EP, Bjornson S, Page CP. Guidelines for clinical care: anti-infective agents for intra-abdominal infection. Arch Surg. 1992;127(1):83–9.Google Scholar
  69. 69.
    Gorbach SL. Antimicrobial prophylaxis for appendectomy and colorectal surgery. Rev Infect Dis. 1991;13(Suppl 10):S815–20.PubMedGoogle Scholar
  70. 70.
    Shafer MA, Sweet RL. Pelvic inflammatory disease in adolescent females. Epidemiology, pathogenesis, diagnosis, treatment and sequelae. Pediatr Clin North Am. 1989;36(3):513–32.PubMedGoogle Scholar
  71. 71.
    Brook I. Aerobic and anaerobic microbiology of necrotizing fascitiis in children. Pediatr Dermatol. 1996;13(4):281–4.CrossRefPubMedGoogle Scholar
  72. 72.
    Brook I, Finegold SM. Aerobic and anaerobic microbiology of cutaneous abscess in children. Pediatrics. 1981;67(6):891–5.PubMedGoogle Scholar
  73. 73.
    Brook I. Microbiology of human and animal bite wounds in children. Pediatr Infect Dis. 1987;6(1):29–32.CrossRefGoogle Scholar
  74. 74.
    Brook I. Anaerobic osteomyelitis in children. Pediatr Infect Dis. 1986;5(5):550–6.CrossRefPubMedGoogle Scholar
  75. 75.
    Brook I, Controni G, Rodriguez WJ, Martin WJ. Anaerobic bacteremia in children. Am J Dis Child. 1980;134(11):1052–6.PubMedGoogle Scholar
  76. 76.
    Fitzerald RA, Rosenblatt J, Tenney JH, Bourgault AM. Anaerobic septic arthritis. Clin Orthop. 1982;164(4):141–8.Google Scholar
  77. 77.
    Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect. 2006;12(6):527–32.CrossRefPubMedGoogle Scholar
  78. 78.
    Brook I, Frazier EH. Microbiology of scalp abscess in newborns. Pediatr Infect Dis J. 1992;11(9):766–8.CrossRefPubMedGoogle Scholar
  79. 79.
    Brook I. Neonatal pneumonia caused by members of the Bacteroides fragilis group. Clin Pediatr. 1977;19(8):541–3.CrossRefGoogle Scholar
  80. 80.
    Brook I. Bacteremia due to anaerobic bacteria in newborns. J Perinatol. 1990;10(4):351–6.PubMedGoogle Scholar
  81. 81.
    Brook I, Martin WJ, Finegold SM. Effect of silver nitrate application on the conjunctival flora of the newborn: and the occurrence of clostridial conjunctivitis. J Pediatr Ophthalmol Strabismus. 1978;15(3):179–83.PubMedGoogle Scholar
  82. 82.
    Brook I. Cutaneous and subcutaneous infections in newborns due to anaerobic bacteria. J Perinat Med. 2002;30(3):197–208.CrossRefPubMedGoogle Scholar
  83. 83.
    Midura TF. Update: infant botulism. Clin Microbiol Rev. 1996;9(2):119–25.PubMedGoogle Scholar
  84. 84.
    Kliegman RM, Ranaroff AA, Izant R, Speck WT. Clostridia as pathogens in neonatal necrotizing enterocolitis. J Pediatr. 1979;95(2):287–98.CrossRefPubMedGoogle Scholar
  85. 85.
    Hecht DW. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing. Anaerobe. 2006;12(3):115–21.CrossRefPubMedGoogle Scholar
  86. 86.
    Appelbaum PC, Spangler SK, Jacobs MR. Susceptibility of 394 Bacteroides fragilis, non B. fragilis group, Bacteroides species, and Fusobacterium species to newer antimicrobial agents. Antimicrob Agents Chemother. 1991;35(6):1214–18.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Georgetown University School of MedicineWashingtonUSA

Personalised recommendations